| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.98 | 0.004 | 0.982 | Antiinflammatory | 0.982 0.004 CHEMBL131 | CHEMBL131 | |
| 0.902 | 0.002 | 0.968 | Androgen antagonist | 0.968 0.001 CHEMBL131 | CHEMBL131 | |
| 0.901 | 0.002 | 0.95 | Hypoxia-inducible factor 1 alpha inhibitor | 0.95 0.002 CHEMBL131 | CHEMBL131 | |
| 0.898 | 0.006 | 0.922 | Transcription factor NF kappa B inhibitor | 0.922 0.004 CHEMBL131 | CHEMBL131 | |
| 0.842 | 0.002 | 0.904 | Antipruritic | 0.904 0.002 CHEMBL131 | CHEMBL131 | |
| 0.84 | 0 | 0.899 | Transcortin receptor antagonist | 0.899 0 CHEMBL131 | CHEMBL131 | |
| 0.841 | 0.005 | 0.89 | Toll-Like receptor 7 agonist | 0.89 0.004 CHEMBL131 | CHEMBL131 | |
| 0.838 | 0.005 | 0.888 | Toll-Like receptor agonist | 0.888 0.004 CHEMBL131 | CHEMBL131 | |
| 0.828 | 0.001 | 0.828 | Aromatase inhibitor | 0.761 0.002 CHEMBL131 | ||
| 0.774 | 0.001 | 0.879 | Androgen agonist | 0.879 0.001 CHEMBL131 | CHEMBL131 | |
| 0.767 | 0.001 | 0.79 | Glucocorticoid agonist | 0.79 0.001 CHEMBL131 | CHEMBL131 | |
| 0.775 | 0.02 | 0.775 | Apoptosis agonist | 0.768 0.02 CHEMBL131 | ||
| 0.739 | 0.004 | 0.77 | Immunosuppressant | 0.77 0.004 CHEMBL131 | CHEMBL131 | |
| 0.73 | 0.006 | 0.73 | Aldehyde oxidase inhibitor | 0.726 0.006 CHEMBL131 | ||
| 0.693 | 0.006 | 0.693 | Nitric oxide antagonist | 0.566 0.012 CHEMBL131 | ||
| 0.671 | 0.001 | 0.792 | Glucocorticoid antagonist | 0.792 0.001 CHEMBL131 | CHEMBL131 | |
| 0.657 | 0.001 | 0.678 | Interferon gamma antagonist | 0.678 0.001 CHEMBL131 | CHEMBL131 | |
| 0.655 | 0.004 | 0.655 | Anesthetic general | 0.5 0.008 CHEMBL131 | ||
| 0.654 | 0.012 | 0.654 | Cholesterol antagonist | 0.575 0.022 CHEMBL131 | ||
| 0.621 | 0.002 | 0.715 | Lipocortins synthesis antagonist | 0.715 0.001 CHEMBL131 | CHEMBL131 | |
| 0.56 | 0.005 | 0.732 | Diuretic | 0.732 0.004 CHEMBL131 | CHEMBL131 | |
| 0.552 | 0.005 | 0.602 | P-glycoprotein inhibitor | 0.602 0.005 CHEMBL131 | CHEMBL131 | |
| 0.52 | 0.002 | 0.745 | Progesterone antagonist | 0.745 0.001 CHEMBL131 | CHEMBL131 | |
| 0.48 | 0.015 | 0.584 | DNA synthesis inhibitor | 0.584 0.008 CHEMBL131 | CHEMBL131 | |
| 0.464 | 0 | 0.517 | Corticosteroid-like | 0.517 0 CHEMBL131 | CHEMBL131 | |
| 0.468 | 0.005 | 0.509 | NOS3 expression enhancer | 0.509 0.005 CHEMBL131 | CHEMBL131 | |
| 0.461 | 0 | 0.509 | Arachidonic acid antagonist | 0.509 0 CHEMBL131 | CHEMBL131 | |
| 0.449 | 0.002 | 0.69 | Aldosterone antagonist | 0.69 0.001 CHEMBL131 | CHEMBL131 | |
| 0.447 | 0.005 | 0.535 | Interleukin 6 antagonist | 0.535 0.004 CHEMBL131 | CHEMBL131 | |
| 0.442 | 0.008 | 0.486 | Lipid peroxidase inhibitor | 0.486 0.005 CHEMBL131 | CHEMBL131 | |
| 0.439 | 0.009 | 0.482 | Sodium/bile acid cotransporter inhibitor | 0.482 0.005 CHEMBL131 | CHEMBL131 | |
| 0.403 | 0.002 | 0.403 | 5-Alpha-reductase inhibitor | 0.398 0.002 CHEMBL131 | ||
| 0.357 | 0.013 | 0.357 | Topoisomerase II inhibitor | 0.337 0.014 CHEMBL131 | ||
| 0.382 | 0.038 | 0.398 | Antioxidant | 0.398 0.035 CHEMBL131 | CHEMBL131 | |
| 0.343 | 0.005 | 0.377 | Estrogen antagonist | 0.377 0.005 CHEMBL131 | CHEMBL131 | |
| 0.371 | 0.035 | 0.503 | Interleukin antagonist | 0.503 0.02 CHEMBL131 | CHEMBL131 | |
| 0.334 | 0.001 | 0.431 | Anabolic | 0.431 0.001 CHEMBL131 | CHEMBL131 | |
| 0.306 | 0.007 | 0.306 | Topoisomerase II alpha inhibitor | 0.301 0.007 CHEMBL131 | ||
| 0.299 | 0.001 | 0.425 | Lipocortins synthesis agonist | 0.425 0 CHEMBL131 | CHEMBL131 | |
| 0.296 | 0.005 | 0.296 | Estrogen agonist | 0.273 0.005 CHEMBL131 | ||
| 0.348 | 0.057 | 0.387 | Apoptosis antagonist | 0.387 0.042 CHEMBL131 | CHEMBL131 | |
| 0.29 | 0.004 | 0.378 | Mineralocorticoid receptor antagonist | 0.378 0.003 CHEMBL131 | CHEMBL131 | |
| 0.296 | 0.012 | 0.331 | Cholesterol synthesis inhibitor | 0.331 0.008 CHEMBL131 | CHEMBL131 | |
| 0.304 | 0.029 | 0.304 | Hepatoprotectant | 0.299 0.03 CHEMBL131 | ||
| 0.265 | 0.001 | 0.265 | Glucose-6-phosphate dehydrogenase inhibitor | 0.132 0.002 CHEMBL131 | ||
| 0.265 | 0.005 | 0.265 | Inducible nitric-oxide synthase inhibitor | 0.188 0.01 CHEMBL131 | ||
| 0.258 | 0.005 | 0.676 | Interleukin 8 antagonist | 0.676 0.003 CHEMBL131 | CHEMBL131 | |
| 0.26 | 0.01 | 0.29 | Farnesoid X receptor antagonist | 0.29 0.007 CHEMBL131 | CHEMBL131 | |
| 0.246 | 0.002 | 0.246 | Progesterone agonist | 0.22 0.002 CHEMBL131 | ||
| 0.307 | 0.069 | 0.333 | Interleukin 2 agonist | 0.333 0.054 CHEMBL131 | CHEMBL131 | |
| 0.268 | 0.029 | 0.28 | Neurotrophic factor enhancer | 0.28 0.024 CHEMBL131 | CHEMBL131 | |
| 0.249 | 0.014 | 0.249 | Antineoplastic antibiotic | 0.241 0.015 CHEMBL131 | ||
| 0.229 | 0.003 | 0.229 | 5-Alpha-reductase 1 inhibitor | 0.193 0.003 CHEMBL131 | ||
| 0.348 | 0.124 | 0.382 | Cyclophilin D inhibitor | 0.382 0.101 CHEMBL131 | CHEMBL131 | |
| 0.225 | 0.003 | 0.225 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | 0.131 0.004 CHEMBL131 | ||
| 0.235 | 0.018 | 0.432 | Alkylator | 0.432 0.006 CHEMBL131 | CHEMBL131 | |
| 0.219 | 0.005 | 0.329 | Interleukin 5 antagonist | 0.329 0.004 CHEMBL131 | CHEMBL131 | |
| 0.355 | 0.141 | 0.478 | Caspase 9 stimulant | 0.478 0.069 CHEMBL131 | CHEMBL131 | |
| 0.294 | 0.08 | 0.395 | Immunostimulant | 0.395 0.051 CHEMBL131 | CHEMBL131 | |
| 0.229 | 0.016 | 0.287 | Interleukin 4 antagonist | 0.287 0.009 CHEMBL131 | CHEMBL131 | |
| 0.226 | 0.02 | 0.24 | DNA intercalator | 0.24 0.018 CHEMBL131 | CHEMBL131 | |
| 0.194 | 0.003 | 0.203 | RNA-directed RNA polymerase stimulant | 0.203 0.003 CHEMBL131 | CHEMBL131 | |
| 0.193 | 0.003 | 0.193 | 5-Alpha-reductase 2 inhibitor | 0.167 0.004 CHEMBL131 | ||
| 0.191 | 0.002 | 0.191 | Heme oxygenase stimulant | 0.116 0.005 CHEMBL131 | ||
| 0.201 | 0.013 | 0.223 | Antineoplastic alkaloid | 0.223 0.008 CHEMBL131 | CHEMBL131 | |
| 0.188 | 0.01 | 0.188 | Transcription factor NF kappa B stimulant | 0.144 0.017 CHEMBL131 | ||
| 0.224 | 0.055 | 0.401 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.401 0.008 CHEMBL131 | CHEMBL131 | |
| 0.242 | 0.085 | 0.342 | DNA damaging | 0.342 0.043 CHEMBL131 | CHEMBL131 | |
| 0.196 | 0.042 | 0.227 | Melanin inhibitor | 0.227 0.033 CHEMBL131 | CHEMBL131 | |
| 0.165 | 0.014 | 0.169 | Toll-Like receptor 4 antagonist | 0.169 0.013 CHEMBL131 | CHEMBL131 | |
| 0.154 | 0.005 | 0.179 | Estrogen receptor alpha agonist | 0.179 0.005 CHEMBL131 | CHEMBL131 | |
| 0.155 | 0.014 | 0.164 | Estrogen receptor beta antagonist | 0.164 0.013 CHEMBL131 | CHEMBL131 | |
| 0.172 | 0.04 | 0.386 | Monophenol monooxygenase inhibitor | 0.386 0.012 CHEMBL131 | CHEMBL131 | |
| 0.138 | 0.009 | 0.147 | Na+ K+ transporting ATPase inhibitor | 0.147 0.006 CHEMBL131 | CHEMBL131 | |
| 0.243 | 0.118 | 0.292 | Caspase 3 stimulant | 0.292 0.083 CHEMBL131 | CHEMBL131 | |
| 0.155 | 0.031 | 0.163 | Ca2+-transporting ATPase inhibitor | 0.163 0.02 CHEMBL131 | CHEMBL131 | |
| 0.128 | 0.004 | 0.128 | Estrone sulfatase inhibitor | 0.114 0.004 CHEMBL131 | ||
| 0.119 | 0.004 | 0.125 | Nitric oxide donor | 0.125 0.004 CHEMBL131 | CHEMBL131 | |
| 0.158 | 0.045 | 0.181 | DNA polymerase I inhibitor | 0.181 0.035 CHEMBL131 | CHEMBL131 | |
| 0.115 | 0.01 | 0.133 | Estrogen receptor beta agonist | 0.133 0.008 CHEMBL131 | CHEMBL131 | |
| 0.126 | 0.034 | 0.126 | Nitric-oxide synthase inhibitor | |||
| 0.108 | 0.023 | 0.237 | Estrogen receptor alpha antagonist | 0.237 0.006 CHEMBL131 | CHEMBL131 | |
| 0.094 | 0.012 | 0.094 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.086 0.014 CHEMBL131 | ||
| 0.088 | 0.012 | 0.139 | Estradiol 17 beta-dehydrogenase inhibitor | 0.139 0.007 CHEMBL131 | CHEMBL131 | |
| 0.073 | 0.005 | 0.073 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.062 0.008 CHEMBL131 | ||
| 0.096 | 0.029 | 0.105 | T cell inhibitor | 0.105 0.02 CHEMBL131 | CHEMBL131 | |
| 0.079 | 0.016 | 0.079 | 11-Beta-hydroxysteroid dehydrogenase 1 inhibitor | 0.049 0.03 CHEMBL131 | ||
| 0.191 | 0.128 | 0.191 | Spasmolytic | |||
| 0.154 | 0.097 | 0.154 | Phospholipase C inhibitor | 0.15 0.106 CHEMBL131 | ||
| 0.11 | 0.057 | 0.168 | Beta glucuronidase inhibitor | 0.168 0.018 CHEMBL131 | CHEMBL131 | |
| 0.083 | 0.035 | 0.099 | Glycine receptor agonist | 0.099 0.022 CHEMBL131 | CHEMBL131 | |
| 0.107 | 0.064 | 0.123 | Topoisomerase I inhibitor | 0.123 0.054 CHEMBL131 | CHEMBL131 | |
| 0.05 | 0.008 | 0.05 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.049 0.009 CHEMBL131 | ||
| 0.124 | 0.088 | 0.124 | Protein kinase stimulant | 0.118 0.095 CHEMBL131 | ||
| 0.106 | 0.07 | 0.106 | GABA receptor agonist | |||
| 0.23 | 0.196 | 0.28 | Antibacterial | 0.28 0.151 CHEMBL131 | CHEMBL131 | |
| 0.085 | 0.052 | 0.085 | Estrogen-related receptor beta agonist | 0.084 0.056 CHEMBL131 | ||
| 0.06 | 0.032 | 0.06 | GABA receptor antagonist | |||
| 0.082 | 0.055 | 0.082 | Ca(v)3.1 blocker | |||
| 0.043 | 0.022 | 0.043 | GABA uptake inhibitor | |||
| 0.055 | 0.035 | 0.055 | GABA A receptor antagonist | |||
| 0.103 | 0.085 | 0.182 | Microtubule formation inhibitor | 0.182 0.024 CHEMBL131 | CHEMBL131 | |
| 0.056 | 0.04 | 0.056 | Pregnane X receptor antagonist | 0.055 0.046 CHEMBL131 | ||
| 0.11 | 0.095 | 0.141 | Bone formation stimulant | 0.141 0.066 CHEMBL131 | CHEMBL131 | |
| 0.079 | 0.064 | 0.079 | GABA A receptor agonist | |||
| 0.124 | 0.114 | 0.161 | Adenylate cyclase stimulant | 0.161 0.046 CHEMBL131 | CHEMBL131 | |
| 0.015 | 0.005 | 0.015 | 3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor | 0.014 0.006 CHEMBL131 | ||
| 0.021 | 0.011 | 0.021 | Progesterone receptor B antagonist | 0.019 0.014 CHEMBL131 | ||
| 0.071 | 0.063 | 0.072 | Keratolytic | 0.072 0.061 CHEMBL131 | CHEMBL131 | |
| 0.083 | 0.077 | 0.083 | Prolactin inhibitor | |||
| 0.016 | 0.013 | 0.016 | Vitamin D receptor agonist | 0.016 0.012 CHEMBL131 | ||
| 0.025 | 0.026 | 0.034 | Hedgehog signaling activator | 0.034 0.007 CHEMBL131 | CHEMBL131 | |
| 0.075 | 0.078 | 0.077 | Thioredoxin reductase inhibitor | 0.077 0.072 CHEMBL131 | CHEMBL131 | |
| 0.068 | 0.08 | 0.104 | Glycine receptor antagonist | 0.104 0.029 CHEMBL131 | CHEMBL131 | |
| 0.086 | 0.1 | 0.124 | Mucolytic | 0.124 0.05 CHEMBL131 | CHEMBL131 | |
| 0.124 | 0.14 | 0.264 | Angiogenesis stimulant | 0.264 0.064 CHEMBL131 | CHEMBL131 | |
| 0.035 | 0.055 | 0.054 | Microtubule stabilization | 0.054 0.022 CHEMBL131 | CHEMBL131 | |
| 0.079 | 0.104 | 0.103 | Bile acid receptor antagonist | 0.103 0.043 CHEMBL131 | CHEMBL131 | |
| 0.015 | 0.048 | 0.023 | Protein 30S ribosomal subunit inhibitor | 0.023 0.019 CHEMBL131 | CHEMBL131 | |
| 0.07 | 0.114 | 0.131 | Expectorant | 0.131 0.044 CHEMBL131 | CHEMBL131 | |
| 0.079 | 0.124 | 0.121 | Amylase inhibitor | 0.121 0.08 CHEMBL131 | CHEMBL131 | |
| 0.077 | 0.126 | 0.123 | Acetylcholine muscarinic antagonist | 0.123 0.064 CHEMBL131 | CHEMBL131 | |
| 0.161 | 0.217 | 0.244 | Immunomodulator | 0.244 0.12 CHEMBL131 | CHEMBL131 | |
| 0.056 | 0.143 | 0.116 | Breast cancer-resistant protein inhibitor | 0.116 0.042 CHEMBL131 | CHEMBL131 | |
| 0.066 | 0.162 | 0.101 | Cholinergic antagonist | 0.101 0.095 CHEMBL131 | CHEMBL131 | |
| 0.065 | 0.162 | 0.098 | Acetylcholine antagonist | 0.098 0.095 CHEMBL131 | CHEMBL131 | |
| 0.078 | 0.19 | 0.155 | Acetylcholine M1 receptor antagonist | 0.155 0.07 CHEMBL131 | CHEMBL131 | |
| 0.134 | 0.246 | 0.18 | Peptidyltransferase inhibitor | 0.18 0.129 CHEMBL131 | CHEMBL131 | |
| 0.058 | 0.174 | 0.169 | Adenylate cyclase inhibitor | 0.169 0.034 CHEMBL131 | CHEMBL131 | |
| 0.101 | 0.225 | 0.156 | Free radical scavenger | 0.156 0.138 CHEMBL131 | CHEMBL131 | |
| 0.1 | 0.236 | 0.291 | Tumour necrosis factor alpha release inhibitor | 0.291 0.057 CHEMBL131 | CHEMBL131 | |
| 0.072 | 0.249 | 0.109 | Interleukin 2 antagonist | 0.109 0.066 CHEMBL131 | CHEMBL131 | |
| 0.082 | 0.269 | 0.149 | Non-steroidal antiinflammatory agent | 0.149 0.116 CHEMBL131 | CHEMBL131 | |
| 0.072 | 0.288 | 0.153 | Growth hormone agonist | 0.153 0.085 CHEMBL131 | CHEMBL131 | |
| 0.097 | 0.353 | 0.252 | Antithrombotic | 0.252 0.124 CHEMBL131 | CHEMBL131 | |
| 0.045 | 0.321 | 0.126 | Cytokine production inhibitor | 0.126 0.083 CHEMBL131 | CHEMBL131 | |
| 0.026 | 0.384 | 0.125 | AMP-activated protein kinase stimulant | 0.125 0.045 CHEMBL131 | CHEMBL131 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |